Drug Pipeline

Avalglucosidase alfa (GZ402666) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
1
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 3
1
Phase 2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06666413 China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With… Glycogen Storage Disease Type II Recruiting
Phase 3
NCT04910776 Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT… Glycogen Storage Disease Type II Active, Not Recruiting
Phase 2
NCT03019406 A Study to Assess Safety and Efficacy of Avalglucosidase Alfa Administered Every Other… Glycogen Storage Disease Type II-Pompe's Disease Active, Not Recruiting
Not specified
NCT05734521 Avalglucosidase Alfa Pregnancy Study Pompe Disease Recruiting
Sponsors Running Avalglucosidase alfa (GZ402666) Trials
Genzyme, a Sanofi Company (2) Sanofi (2)
Get alerts when Avalglucosidase alfa (GZ402666) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free